2026 Partners

The National Physical Laboratory (NPL) is a National Laboratory spanning Science, Innovation and Technology. NPL is ideally positioned to support delivery of the multi-disciplinary potential of Engineering Biology (EngBio) through the development of traceable measurement science tools and solutions, necessary for the successful characterisation and exploitation of biological systems.  

Advances in EngBio enabled solutions will be driven through collaboration built on a foundation of reliable, repeatable and comparable measurement systems which are easily transferred between manufacturers in the same way that metrology is critical in other advanced manufacturing disciplines from aircraft to semiconductors. Today, NPL is supporting UK companies to accelerate innovation and enable scale-up of EngBio driven technologies through the development of physical reference materials, standardised analytical methodologies, internationally recognised standards and the development of best practice guidance documents.  

NPL is also collaborating across the EngBio ecosystem both in the UK and internationally to understand and support the next generation of engineering biology solutions, including the requirements for the application of AI and machine learning, the development of process control and modelling systems, alongside support for standards and regulatory requirements working with our partners across the International Measurement System laboratories to ensure UK leadership and alignment on standards and standardisation to support growth and trade.

At Twist Bioscience, we work in service of customers who are changing the world for the better. In fields such as medicine, agriculture and industrial chemicals, by using our synthetic DNA tools, our customers are developing ways to better lives and improve the sustainability of the planet. The faster our customers succeed, the better for all of us, and Twist Bioscience is uniquely positioned to help accelerate their efforts.

Our innovative silicon-based DNA Synthesis Platform provides precision at a scale that is otherwise unavailable to our customers. Our platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis, sequencing and therapeutics discovery, providing both the quality and quantity of the tools they need to most rapidly realize the opportunity ahead. For more information about our products and services, please visit www.twistbioscience.com.

For more than 35 years, Integrated DNA Technologies, Inc. (IDT) has been empowering genomics laboratories with an oligonucleotide manufacturing process unlike anyone else in the industry, with the most advanced synthesis, modification, purification, and quality control capabilities available. Since its founding in 1987, IDT has progressed from a leading oligo manufacturer to a genomics solutions provider supporting key application areas such as next generation sequencing, CRISPR genome editing, synthetic biology, digital PCR, and RNA interference. Through its GMP* services, IDT manufactures products used by scientists researching many forms of cancer and most inherited and infectious diseases. As the company seeks to fulfil its mission of accelerating the pace of genomics, the important acquisition of Archer™ NGS Research Assays was completed in Dec. 2022. When combined with its existing solutions, the expanded portfolio helps realize the shared vision of enabling researchers to rapidly move from the lab to life-changing advances.

New England Biolabs® (NEB®) is renowned for service excellence and exceptional product quality. NEB manufactures molecular biology reagents and is an industry leader in the supply of restriction enzymes, polymerases, modifying enzymes and sample preparation for next generation sequencing. The NEB offering includes E.coli expression systems, competent cells, reagents for PCR, qPCR, nucleic acid purification, synthetic biology, glycobiology, epigenetics, in vitro transcription (IVT), RNA analysis and DNA ladders.

Additionally, NEB is focused on strengthening alliances that enable our innovations in enzymology to be used in new technologies for today’s biotechnology discovery and development processes, including molecular diagnostics development

Beckman Coulter Life Sciences delivers time-saving solutions in the laboratory through sustainable automation and innovation in liquid handling, genomics, flow cytometry, particle analysis, and centrifugation workflows to advance research and human health for a better tomorrow. 

CPI is a pioneering innovation organisation and part of the High Value Manufacturing Catapult, helping businesses develop, scale-up and commercialise advanced technologies and manufacturing solutions.

CPI applies our expertise in Engineering Biology to sectors including AgriFoodTech, HealthTech, Advanced Materials and Pharmaceuticals, combining specialist expertise with world-class facilities and infrastructure.

We support organisations to translate innovations, developed using engineering biology, towards commercialisation, offering open-access specialist lab, pilot and demonstration scale infrastructure and a range of specialist expertise across early-stage strain development, upstream and downstream process development, process engineering and biomanufacturing.

Established in 2016, the Singapore Consortium for Synthetic Biology (SINERGY) is a national platform dedicated to advancing synthetic biology innovation and fostering a vibrant bio-based economy in Singapore. SINERGY brings together academia, industry and government agencies to facilitate research collaborations, technology translation, talent development and international partnerships. Through strategic networking, knowledge exchange and industry engagement, SINERGY aims to strengthen Singapore’s synthetic biology ecosystem and position the nation as a global hub for engineering biology and the bioeconomy.

As a global leader in laboratory and clinical technologies, Agilent is committed to helping scientists bring great science to life. As they pursue small, everyday advances and life-changing discoveries, we provide trusted answers to scientists’ and clinicians’ most critical questions and challenges. Leveraging more than 50 years of expertise, we create advanced instruments, software, and consumables supported by teams of highly skilled and knowledgeable people.

Our comprehensive solutions produce the most accurate results as well as optimal scientific, economic, and operational outcomes. By working collaboratively with our customers and supporting their needs, we help them bring great science to food, pharma, environment, energy, chemical, academic research, and clinical fields.

Engineering Biology is a fully open access journal sharing the latest developments on biological devices and systems designed using engineering techniques and practices for a wide range of applications. We welcome papers from all stages of the design cycle from the development of platform technology and techniques, to industrial and scaling processes, and new technical standards.

Overseen by Editors-in-Chief Professor Richard Kitney (Imperial College London) and Dr Chueh Loo Poh (National University of Singapore) and published by The Institution of Engineering and Technology (IET) in partnership with Wiley, all articles are openly accessible to read and share worldwide. Gain valuable insight into the latest advances in engineering biology, or raise your profile and be a part of our community of authors.

Contact the Executive Editor Dr Helen Dyball hdyball@theiet.org if you would like further information about contributing, or visit http://wileyonlinelibrary.com/iet-enb to see the latest publications and to find out more about the journal.

Sciad Communications is a leading science marketing and communications agency for the life science, biotech, healthcare and engineering sectors. Our talented team of communicators, scientists, marketeers and designers work with organisations that have a vision to shape the future.